Dr. Ravid Straussman completed a BS summa cum laude at the Hebrew University Hadassah Medical School. He earned his MSc in Medical Biochemistry and then graduated the MD/PhD program of Hadassah Medical School followed by an MD internship. After completed a short post-doc training period at the lab of Dr. Howard Cedar he joined the lab of Dr. Todd Golub at the Broad institute of Harvard and MIT for a second post doc training period where he studied the effects of the tumor microenvironment on chemoresistance. At 2013 he joined the Weizmann Institute as a principal investigator. The Straussman lab studies mechanisms of resistance to anti-cancer therapies. Specifically the lab focuses on understanding the roles of the tumor microenvironment and the tumor microbiome on resistance to cytotoxic, targeted and immune mediated anti-cancer therapies.
« Go Back